Surgery, Gastroenterology and Oncology
Vol. 20, No. 3, September 2015
Neonatal Graves-Basedow disease due to long-standing TRAb persistence following total thyroidectomy
Emiliana Teodora Dragomir-Ananie, Camelia Procopiuc, Florea Caliopsia, Maricica Gusa, Carmen Cristina Diaconu
CASE REPORT, September 2015
Article DOI: 10.21614/jtmr-20-3-51
Background: Neonatal Graves-Basedow disease is a rare and transient complication due to mother's Basedow disease, occurring extremely rare due to Hashimoto thyroiditis or as a persistent hyperthyroidism due to activating mutations of the Thyroid-Stimulating Hormone (TSH) receptor. It may cause goiter and hyperthyroidism in the neonate, prematurity or fetal death, in some cases needing therapy and pre-conception counseling.

Case presentation: We report the case of a premature newborn from a mother who underwent total thyroidectomy for Basedow disease 7 years before conception, euthyroid before and during pregnancy on levothyroxine therapy. The mother was not checked for antibodies against thyroid stimulating hormone (TSH) receptor (TRAb) persistence before pregnancy. Despite response to antithyroid therapy, hyperthyroidism, cardiac congenital disease and prematurity complicated the evolutionof the newborn, leading to death in the 27th day of life.

Conclusion: The case is interesting due to long-standing persistence of TRAb after total thyroidectomy and the severe impact of hyperthyroidism in the fetus and neonate, despite low circulating levels of TRAb in mother which point out that other microenvironmental and or genetic factors might be involved in the dramatic demise of the neonate. Fertile-aged women should be counseled.

Keywords: Neonatal Graves-Basedow disease, neonatal hyperthyroidism, TSH receptor mutations polymorphisms, pre-conception counseling

Full Text Sources: Download pdf
Abstract:   Abstract EN
Views: 3495


Watch Video Articles


For Authors



Journal Subscriptions

Current Issue

Dec 2025

Supplements

Instructions for authors
Online submission
Contact
ISSN: 2559 - 723X (print)

e-ISSN: 2601 - 1700 (online)

ISSN-L: 2559 - 723X

Journal Abbreviation: Surg. Gastroenterol. Oncol.

Surgery, Gastroenterology and Oncology (SGO) is indexed in:
  • SCOPUS
  • EBSCO
  • DOI/Crossref
  • Google Scholar
  • SCImago
  • Harvard Library
  • Open Academic Journals Index (OAJI)

Open Access Statement

Surgery, Gastroenterology and Oncology (SGO) is an open-access, peer-reviewed online journal published by Celsius Publishing House. The journal allows readers to read, download, copy, distribute, print, search, or link to the full text of its articles.

Journal Metrics

Time to first editorial decision: 25 days
Rejection rate: 61%
CiteScore: 0.2



Meetings and Courses in 2025
Meetings and Courses in 2024
Meetings and Courses in 2023
Meetings and Courses in 2022
Meetings and Courses in 2021
Meetings and Courses in 2020
Meetings and Courses in 2019
Verona expert meeting 2019

Creative Commons License
Surgery, Gastroenterology and Oncology applies the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits readers to copy and redistribute the material in any medium or format, remix, adapt, build upon the published works non-commercially, and license the derivative works on different terms, provided the original material is properly cited and the use is non-commercial. Please see: https://creativecommons.org/licenses/by-nc/4.0/
Publisher’s Note:
The opinions, statements, and data contained in article are solely those of the authors and not of Surgery, Gastroenterology and Oncology journal or the editors. Publisher and the editors disclaim responsibility for any damage resulting from any ideas, instructions, methods, or products referred to in the content.